《復牌表現》新威(00058.HK)曾飆逾2倍探頂 主席溢價25%增購股份觸提全購
新威國際(00058.HK)主席溢價25%增購股份觸發提全購,該股停牌逾一個月後今早復牌最多飆升2.1倍至0.248元,創逾年半高無以為繼,升幅大幅收窄至69%,報0.135元,成交急增至4,746萬股,為逾八個月最多,涉資786萬元。
新威公布,以每股0.1元(較停牌前溢價20%)向主要股東兼主席詹世佑發行1.49億股新股或佔擴大後股本16.6%,所得淨額1,390萬元將用作一般營運資金。完成後,詹氏及其一致行動人士持股將由目前29.92%增至41.54%,須按例以同價提出強制有條件全面要約,料涉資約5,300萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.